Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of Interferon-gamma 1b in patients with candidemia. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Candidemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING